Usefulness of cognitive targeting in multiparametric MRI-guided biopsy to diagnose the dominant lesion in prostate cancer - Abstract

OBJECTIVE: To evaluate the safety and efficacy of cognitive targeting in multiparametric MRI-guided biopsy to obtain samples of the dominant nodule in prostate cancer.

MATERIAL AND METHODS: We performed cognitive-targeted biopsy after multiparametric MRI in 53 patients with progressive elevation of PSA. All patients provided written informed consent. Biopsies were done via a transperineal route under ultrasound guidance. The first three samples were obtained by cognitive targeting, with the target lesion determined by multiparametric MRI according to the PI-RADS (prostate imaging, reporting, and data system) criteria. Then 9 cylinders were obtained from the remaining segments of the prostate (systematic biopsies). The pathologist evaluated the 12 cylinders without knowing which ones were obtained by cognitive targeting. In patients with multifocal lesions, we defined the dominant lesion as the one with the highest Gleason score and tumor volume; in patients with unifocal lesions, we defined the dominant lesion as the lesion identified.

RESULTS: We diagnosed 29 prostate tumors. In 89.7% (26/29), the dominant nodule was diagnosed by the cognitive-targeted biopsy. If only cognitive-targeted biopsy had been done, the dominant nodule would not have been diagnosed in two (3.8%, 2/53) patients and only one (1.8%, 1/53) patient, in whom no sample was obtained from the lesion with the highest Gleason score, would have been understaged. The rate of positivity of cognitive-targeted biopsy was 50.9% (27/53) in the entire group of patients and 46.3% (19/41) in the group of patients with previous negative biopsies. No significant immediate or late complications were observed.

CONCLUSION: Cognitive targeting is safe and efficacious for detecting the dominant lesion in prostate cancer.

Written by:
Garcia Bennett J, Conejero Olesti A, Hurtado Salom C, Rebenaque E, Parada D, Serrano Alcalá E, Abreu De Con JA.   Are you the author?
Departamento de Radiología, Hospital St Joan de Reus, Reus, España; Departamento de Anatomía Patológica, Hospital St Joan de Reus, Reus, España; Facultad de Medicina, Universidad Rovira i Virgili, Reus, España.  

Reference: Radiologia. 2014 Nov 22. pii: S0033-8338(14)00166-0.
doi: 10.1016/j.rx.2014.06.008

PubMed Abstract
PMID: 25464931 Prostate Cancer Section


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.